Nevro (NVRO) Names New CEO, Announces Board Appointments and Agreement with Broadfin Capital
Tweet Send to a Friend
Nevro Corp. (NYSE: NVRO) ("Nevro"), a global medical device company that is providing innovative evidence-based solutions for the treatment of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
